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Much of gene regulation is carried out by proteins that bind DNA
or RNA molecules at specific sequences. One class of such proteins
is transcription factors, which bind short DNA sequences to regu-
late transcription. Another class is RNA binding proteins, which
bind short RNA sequences to regulate RNA maturation, transport,
and stability. Here, we study the robustness and evolvability of
these regulatory mechanisms. To this end, we use experimental
binding data from 172 human and fruit fly transcription factors
and RNA binding proteins as well as human polymorphism data
to study the evolution of binding sites in vivo. We find little dif-
ference between the robustness of regulatory protein–RNA inter-
actions and transcription factor–DNA interactions to DNA muta-
tions. In contrast, we find that RNA-mediated regulation is less
evolvable than transcriptional regulation, because mutations are
less likely to create interactions of an RNA molecule with a new
RNA binding protein than they are to create interactions of a gene
regulatory region with a new transcription factor. Our observa-
tions are consistent with the high level of conservation observed
for interactions between RNA binding proteins and their target
molecules as well as the evolutionary plasticity of regulatory
regions bound by transcription factors. They may help explain
why transcriptional regulation is implicated in many more evo-
lutionary adaptations and innovations than RNA-mediated gene
regulation.
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Gene expression is regulated at multiple levels ranging fromthe accessibility of chromatin to the posttranslational mod-
ification of proteins. Much of this regulation is carried out by
sequence-specific, nucleotide-binding proteins that target DNA
or RNA molecules. Transcription factors (TFs) are one such
class of proteins. They bind short DNA sequences to regulate
gene expression at the level of transcription by activating or
blocking the recruitment of RNA polymerase to the transcription
start site (1). RNA binding proteins (RBPs) are another such
class of proteins. They bind short RNA sequences to regulate
gene expression posttranscriptionally by regulating the splicing
of precursor mRNA as well as the stability, transport, transla-
tion, and decay of mature mRNA (2).
Mutations that affect the regulation of gene expression are
often deleterious. This is evidenced by the numerous diseases
associated with mutations in the nucleic acid binding sites of reg-
ulatory proteins (3–6). For example, spinal muscular atrophy, a
pediatric neurodegenerative disorder, is caused by a point muta-
tion in an exonic splicing element, which abrogates binding of an
RBP and results in aberrant exon splicing. Such mutations are
not rare. For instance, of 2,931 disease-associated SNPs located
within regulatory DNA, 93.2% fall within sequences that bind
TFs (5). It is, therefore, important that protein–nucleotide inter-
actions are to some extent robust to mutation.
Changes in the regulation of gene expression need not be dele-
terious. They can also be adaptive and drive evolutionary change
(7–10). For example, single-nucleotide mutations in the binding
sites of TFs that regulate the expression of Drosophila Rhodopsin
genes led to the restricted expression of these genes in specific
subsets of photoreceptors. This change in gene expression facil-
itated the discrimination of a wide spectrum of optical stimuli
and likely provided a selective advantage to the fly (11). It is,
therefore, also important that protein–nucleotide interactions
are evolvable, meaning that mutations to nucleic acid binding
sites have the potential to bring forth new binding phenotypes.
That is, they can change which protein a sequence binds, because
such a change may lead to an adaptive change in the level, timing,
or location of gene expression.
Robustness and evolvability are often studied within the con-
text of a genotype–phenotype map (12, 13), an object of cen-
tral importance in the biological sciences (14–16). Most of
what we know about genotype–phenotype maps comes from
computational models of biological systems (17–23). The two
most prominent examples are models that predict the secondary
structure phenotypes of RNA sequence genotypes (18) and
the lattice-based structural phenotypes of simplified amino acid
sequence genotypes (17). Analyses of these and other mod-
els have revealed three hallmark characteristics of genotype–
phenotype maps (24): (i) many genotypes encode the same
phenotype, (ii) the number of genotypes per phenotype has a
highly nonuniform distribution, and (iii) genotype networks [also
known as neutral networks (18)] mutationally connect sets of
genotypes that have the same phenotype (25). The existence of
genotype networks is important for at least two reasons. First, a
Significance
Cells regulate the activity of genes in a variety of ways.
For example, they regulate transcription through DNA bind-
ing proteins called transcription factors, and they regulate
mRNA stability and processing through RNA binding pro-
teins. Based on current knowledge, transcriptional regulation
is more widespread and is involved in many more evolution-
ary adaptations than posttranscriptional regulation. The rea-
son could be that transcriptional regulation is studied more
intensely. We suggest instead that transcriptional regulation
harbors an intrinsic evolutionary advantage: when mutations
change transcriptional regulation, they are more likely to
bring forth novel patterns of such regulation. That is, tran-
scriptional regulation is more evolvable. Our analysis suggests
a reason why a specific kind of gene regulation is especially
abundant in the living world.
Author contributions: J.L.P. and A.W. designed research; J.L.P. and F.K. performed
research; J.L.P., F.K., and A.W. analyzed data; and J.L.P. and A.W. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission. R.S. is a guest editor invited by the Editorial
Board.
This open access article is distributed under Creative Commons Attribution-
NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
1 To whom correspondence should be addressed. Email: joshua.payne@env.ethz.ch.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1719138115/-/DCSupplemental.
Published online March 26, 2018.
www.pnas.org/cgi/doi/10.1073/pnas.1719138115 PNAS | vol. 115 | no. 15 | E3481–E3490
mutation to any one genotype on the network has the potential to
produce another genotype that is also on the network and there-
fore, also has the same phenotype. Second, genotype networks
tend to spread far throughout the space of all possible genotypes,
which provides mutational access to the genotype networks of
different phenotypes. Genotype networks, therefore, confer both
robustness and evolvability to phenotypes (25).
The study of genotype–phenotype maps is currently being
transformed by technological advances in high-throughput
sequencing and chip-based technologies (26–43) as well as by
synthetic biology (44). These approaches facilitate the assign-
ment of phenotypes to a large number of genotypes and thus,
provide the opportunity to empirically characterize a genotype–
phenotype map. Examples of such phenotypes include the abil-
ity of RNA molecules to bind an aptamer (29), the fluorescent
activity of proteins (39), and the formation of a spatial stripe
by synthetic gene regulatory circuits (44). For some genotype–
phenotype maps, a phenotype can be assigned to all possi-
ble genotypes. Specifically, protein binding microarrays provide
measurements of the affinity with which a TF binds to all possi-
ble 8-nt DNA sequences (45), and RNAcompete provides mea-
surements of the affinity with which an RBP binds to all but two
of the possible 7-nt RNA sequences (46). Data like these can
be thought of as exhaustively enumerated, empirically derived
genotype–phenotype maps, where the genotype is a DNA or
RNA sequence and the phenotype is the molecular capacity of
the sequence to bind a TF or RBP, respectively (31).
Here, we use experimental data from protein binding microar-
rays and RNAcompete to study and compare the robustness and
evolvability of the nucleic acid binding sites of TFs and RBPs
via a comparative analysis of their genotype–phenotype maps.
In these maps, a genotype is a nucleic acid sequence, and a
phenotype is the molecular capacity of the sequence to bind a
TF or RBP. These genotype–phenotype maps are particularly
amenable to comparative analysis because of the many similari-
ties between these two forms of protein–nucleotide interactions.
For example, the biophysics of binding are similar for the two
nucleic acids, such that binding affinity between nucleotides in
the DNA or RNA sequence and amino acids in the protein’s
binding domain is largely determined via intermolecular inter-
actions, such as ionic and hydrogen bonding (47, 48). Addition-
ally, the number of DNA sequences profiled by protein binding
microarrays is of the same order of magnitude as the number
of RNA sequences profiled by RNAcompete, and this num-
ber is small enough to facilitate the exhaustive analysis of bind-
ing preferences for many TFs and RBPs (49, 50). Finally, both
of these datasets exhibit the three hallmark characteristics of
genotype–phenotype maps: (i) multiple distinct sequences bind
the same protein (49, 50); (ii) some proteins are bound by
many distinct sequences, whereas others are bound by very few
(49, 50); and (iii) the sequences that bind a protein tend to
form a single-genotype network (31, 51). Despite these sim-
ilarities, we show here that these two genotype–phenotype
maps exhibit pronounced architectural differences, which sug-
gest that the nucleic acid binding sites of RNA-mediated
gene regulation are less evolvable than those of transcriptional
regulation.
Results
Protein Binding Microarray and RNAcompete Data. We use exper-
imental data from protein binding microarrays (50) and RNA-
compete (49) to construct and compare two empirical genotype–
phenotype maps. These data are comparable, because both
technologies use the same analysis pipeline to transform the flu-
orescent intensities of microarray spots into an enrichment score
(E -score) for all possible sequences of a short length. The E -
score is a variant of the Wilcoxon–Mann–Whitney statistic that
ranges from −0.5 to 0.5 and describes the relative binding pref-
erences of a protein to its nucleic acid ligands, with larger num-
bers indicating increased preference. Protein binding microar-
rays profile the binding specificity of a TF by assigning anE -score
to all 32,896 possible 8-nt DNA sequences, whereas RNAcom-
pete profiles the binding specificity of an RBP by assigning an
E -score to 16,382 7-nt RNA sequences (Materials and Methods).
By setting a threshold on the E -score distribution, one can delin-
eate sequences that specifically bind a TF or RBP from those
that do not. Thus, we can assign the binary phenotype of bound
or unbound to each sequence respective to each TF and RBP.
To do so, we use an E -score threshold of 0.35 following earlier
work (31, 41, 52, 53) (Materials and Methods). In SI Appendix, we
consider more stringent binding affinity thresholds to show that
our findings are qualitatively insensitive to this parameter.
Because there are currently far more protein binding microar-
ray data available than RNAcompete data, we choose our study
species according to the availability of the RNAcompete data.
Specifically, we study proteins from Drosophila melanogaster and
Homo sapiens, because these species have more RNAcompete
data available than any other species (Materials and Methods,
Table 1, and Dataset S1). These proteins include 38 TFs and 71
RBPs from H. sapiens as well as 30 TFs and 33 RBPs from D.
melanogaster.
We construct a genotype network for each TF and for each
RBP. In such a network, vertices represent sequences that bind
the TF or RBP (E -score> 0.35), and edges connect vertices if
their corresponding sequences differ by a single small mutation
(Materials and Methods) (31). Since some sequences bind mul-
tiple TFs or RBPs, genotype networks may overlap. Addition-
ally, the sequences that bind a TF or RBP sometimes form mul-
tiple, disconnected genotype networks (SI Appendix, Table S1).
In this case, there is always one genotype network that is much
larger than the others (Dataset S1). We restrict our analyses to
this largest genotype network for each TF and RBP as in our pre-
vious work (31, 41, 51).
Fig. 1 shows the sizes of the genotype networks of TF and RBP
binding sites, expressed as fractions of genotype space, for both
D. melanogaster and H. sapiens. We consider this fractional size
rather than absolute size to facilitate the comparison of these
two genotype–phenotype maps, which differ in the sizes of their
respective genotype spaces. The range of fractional genotype net-
work sizes is similar for the two classes of proteins, although there
Table 1. Data analyzed in this study
Type of No. of proteins No. of proteins No. of binding domain
protein Species in the database in our dataset classes in our dataset
TF H. sapiens 41 38 (29) 11 (9)
TF D. melanogaster 30 30 (23) 10 (7)
RBP H. sapiens 77 71 (38) 9 (5)
RBP D. melanogaster 48 33 (20) 4 (4)
A protein was included in our dataset if it bound at least one sequence (E-score> 0.35). Numbers
in parentheses correspond to a reduced dataset, in which we only consider proteins that have a
genotype network that occupies >0.5% of the genotype space.
E3482 | www.pnas.org/cgi/doi/10.1073/pnas.1719138115 Payne et al.
EV
O
LU
TI
O
N
0 0.01 0.02 0.03
Fractional size of
genotype network
0
5
10
15
20
N
um
be
r o
f R
BP
s
C
0
5
10
15
20
N
um
be
r o
f T
Fs A
0 0.01 0.02 0.03
Fractional size of
genotype network
0
5
10
15
20 D
0
5
10
15
20 B
Fig. 1. Distributions of genotype network sizes. Histograms of the fractional
sizes of the genotype networks of TF binding sites in (A) D. melanogaster
and (B) H. sapiens and of RBP binding sites in (C) D. melanogaster and (D)
H. sapiens. Fractional size is defined as the number of binding sites in the
genotype network divided by the number of binding sites in genotype space.
The dashed vertical lines correspond to a fractional size of 0.005, which we
use as a threshold in supplementary analyses to determine the sensitivity of
our results to the removal of proteins with small genotype networks. Sum-
mary statistics of the data shown in this figure and all others are provided in
Dataset S2.
are fewer small genotype networks of TF binding sites than of RBP
binding sites. For example, 16 genotype networks of TF binding
sites (24%) occupy less than 0.5% of genotype space, whereas 46
genotype networks of RBP binding (44%) sites occupy less than
0.5% of genotype space (dashed vertical lines in Fig. 1).
Robustness. The mutational robustness of an individual binding
site refers to the likelihood that a mutation in this site leaves
binding intact. We quantify this robustness as the fraction of all
possible mutations that yield a sequence that is part of the same
genotype network. We then generalize this quantity by comput-
ing the average robustness of all sites that bind a given TF or
RBP (31, 54), which provides a measure of binding site robust-
ness specific to any one nucleic acid binding protein.
The distributions of robustness are similar for binding sites
of TFs and RBPs (Fig. 2 A–D). On average, the robustness of
D. melanogaster TFs is 0.33, whereas the average robustness of
RBPs is 0.27. A nearly identical pattern is found in H. sapiens,
where the average robustness for TFs is 0.33 compared with 0.26
for RBPs. However, the left-hand tail of the distribution is longer
for RBPs. This means that some RBPs have considerably lower
robustness than any of the TFs (P =0.044 for D. melanogaster
andP =0.002 for H. sapiens, one-sided Wilcoxon rank sum test).
For example, nine of the D. melanogaster RBPs are less robust
than the least robust TF.
To determine why robustness can be higher for TFs than
for RBPs, we studied the relationship between robustness and
genotype network size. Fig. 2E shows that robustness increases
approximately logarithmically with the size of the genotype net-
work for both classes of proteins and in both species. This rela-
tionship may be a generic property of genotype–phenotype maps
as computational models suggest (23, 24, 55, 56). The white sym-
bols in the lower left-hand corner of the plot in Fig. 2E show that
the low-robustness RBPs have small genotype networks. This
indicates that robustness is often higher for TFs, because they
do not have genotype networks as small as RBPs.
Evolvability. In the context of nucleic acid binding sites,
evolvability is the propensity of a mutation to bring forth a new
binding phenotype (31). We quantify the evolvability of a TF’s or
RBP’s binding sites in two steps. First, we determine the set of
sequences that differ by a single mutation from any of the pro-
tein’s binding sites but that are not part of the protein’s geno-
type network. Second, we determine the fraction of TFs or RBPs
in our dataset that these one-mutant neighbors bind (31, 54).
This fraction is our measure of evolvability. It takes on high val-
ues when the one-mutant neighbors of a genotype network bind
many TFs or RBPs and low values when the sequences neighbor-
ing a genotype network bind few TFs or RBPs.
We find that TF binding sites are considerably more evolvable
than RBP binding sites in both D. melanogaster and H. sapi-
ens (Fig. 3 A–D) (P < 10−5 for both comparisons, one-sided
Wilcoxon rank sum test). For example, in D. melanogaster, 29
of 30 TFs are more evolvable than even the most evolvable RBP.
More generally, mutations to TF binding sites have the poten-
tial to create binding sites for 96% of the TFs in our dataset (65
TFs) on average, whereas mutations to RBP binding sites have
the potential to create binding sites for 60% of the RBPs in our
dataset (62 RBPs) on average. This means that the average evolv-
ability of TFs is more than 1.5 times that of RBPs in both species.
Mutations to TF binding sites are, therefore, more likely to bring
forth new binding phenotypes than are mutations to RBP bind-
ing sites.
We next studied the relationship between evolvability and
genotype network size to better understand how the genotype
networks of different binding phenotypes are distributed in the
genotype spaces of the two genotype–phenotype maps. Fig. 3E
shows that evolvability increases with genotype network size for
both TFs and RBPs but that the rate of increase is slower for
RBPs. This raises the possibility that nucleic acid binding phe-
notypes are arranged differently in the two genotype spaces,
because genotype networks of similar size confer different lev-
els of evolvability as do phenotypes of similar robustness (SI
Appendix, Fig. S1). Perhaps genotype networks of TF binding
sites are nearer to one another in genotype space than are
those of RBP binding sites? To find out, we calculated the aver-
age mutational distance between all pairs of genotypes from
different genotype networks for all pairs of TFs and for all
pairs of RBPs. This measure provides a sense of the proxim-
ity of genotype networks in genotype space. Fig. 4A shows that
genotype networks of TF binding sites tend to be separated
by fewer mutations than genotype networks of RBP binding
sites (P < 10−5 for both comparisons, one-sided Wilcoxon rank
sum test). Complementing this analysis, we also characterized
the extent of overlap among pairs of genotype networks, where
the overlap of two genotype networks is defined as the num-
ber of binding sites that they have in common. Fig. 4B shows
that the genotype networks of TF binding sites have more sites
in common than the genotype networks of RBP binding sites
(P < 10−5 for both comparisons, one-sided Wilcoxon rank sum
test). These patterns are consistent among pairs of proteins
that have the same or different binding domains (SI Appendix,
Figs. S2 and S3). Large genotype networks, therefore, confer
evolvability in both genotype–phenotype maps, but the extent
of this evolvability depends on how the phenotypes are distrib-
uted throughout genotype space, a property that varies among
the maps.
To find out more generally how mutations to binding sites can
bring forth novel binding phenotypes, we calculated the number
of unique binding phenotypes that are found within n mutations
of a focal genotype (18). We performed two variants of this anal-
ysis. In the first, we only considered genotypes within n muta-
tions of any one genotype if they belonged to the same genotype
network as the focal genotype (i.e., the nucleic acid sequences
bind the same protein). Because any one of these nucleic acid
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Fig. 2. The binding sites of TFs and RBPs are similarly robust to mutation. Histograms of the distribution of mutational robustness for TF binding sites in (A)
D. melanogaster and (B) H. sapiens and for RBP binding sites in (C) D. melanogaster and (D) H. sapiens. (E) Robustness is shown in relation to the fractional
size of the genotype network, showing that the leftmost tails of the robustness distributions for RBP binding sites in C and D correspond to small genotype
networks. Note the logarithmic scale of the x axis.
sequences may also bind other proteins, this analysis amounts
to a further characterization of genotype network overlap. Fig.
5 shows that, for any number n of mutations, a greater pro-
portion of binding phenotypes can be reached in the genotype
space of transcriptional regulation than in that of RNA-mediated
gene regulation. For example, with just a single mutation (n =1),
39% of D. melanogaster TFs and 23% of H. sapiens TFs can be
reached compared with 25% of D. melanogaster RBPs and 9%
of H. sapiens RBPs. This difference is even more pronounced
at the largest number of mutations (n =8 for TFs and n =7 for
RBPs), where 75% of D. melanogaster TFs and 67% of H. sapiens
TFs can be reached compared with just 44% of D. melanogaster
RBPs and 23% of H. sapiens RBPs. In the second variant of this
analysis, we considered all genotypes within a given number of n
mutations of a focal genotype, regardless of whether these geno-
types belong to the same genotype network as the focal genotype
(i.e., regardless of whether the nucleic acid sequences bind the
same protein). This measure, therefore, simultaneously charac-
terizes the overlap and juxtaposition of genotype networks. SI
Appendix, Fig. S4 shows that, at any number of n mutations,
one can reach at least as many and usually more novel binding
phenotypes for TFs than for RBPs. As the mutational radius
approaches the diameter of the genotype space, the fraction of
reachable phenotypes will necessarily approach one. However,
the number of mutations at which this occurs is always smaller
in the genotype space of TF binding sites than in the genotype
space of RBP binding sites. For example, in D. melanogaster,
all phenotypes only become reachable for RBP binding sites at
the largest possible number of n =7 mutations, whereas n =4
mutations—just one-half of the maximum distance—suffice to
reach all TF binding phenotypes. In sum, both variants of this
analysis show that the nucleic acid binding sites of transcrip-
tional regulation are more evolvable, because a given num-
ber of mutations can reach a larger number of new binding
phenotypes.
At least some of the reduced robustness and evolvability of
RBP binding sites relative to TF binding sites stems from the
presence of small genotype networks in our RBP dataset. This
raises the question of whether the abundance of small geno-
type networks is truly a characteristic feature of this genotype–
phenotype map or is actually the result of a sampling bias in our
dataset. Such bias could occur if our dataset includes a nonrepre-
sentative proportion of RBPs that have small genotype networks.
One way to determine if this bias exists is to compare the dis-
tributions of the number of bound sequences per RBP in our
dataset with those of the remaining 68 RBPs for which binding
data are available (Materials and Methods). The two distributions
are statistically indistinguishable (P =0.24, Wilcoxon rank sum
test) (SI Appendix, Fig. S5). To the extent that the RNAcompete
data are representative of RBP binding preferences in general,
this suggests that small genotype networks are indeed a charac-
teristic feature of the genotype–phenotype map of RBP binding
sites. In SI Appendix, we also show that our main conclusions are
insensitive to the removal of proteins with small genotype net-
works (SI Appendix, Figs. S6–S8) and to the single-nucleotide
difference in the lengths of the TF and RBP binding sites that
we study (SI Appendix, Figs. S9–S12). Additionally, we show that
our main conclusions are insensitive to the relaxation of some of
our modeling assumptions, including the affinity threshold used
to delineate bound from unbound sequences (SI Appendix, Figs.
S13–S18) and the exclusion of small genotype network compo-
nents from our evolvability measure (SI Appendix, Fig. S19).
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Fig. 3. TF binding sites are more evolvable than RBP binding sites. Histograms of the distribution of evolvability for TF binding sites in (A) D. melanogaster
and (B) H. sapiens and for RBP binding sites in (C) D. melanogaster and (D) H. sapiens. (E) Evolvability is shown in relation to the fractional size of the
genotype network, showing that evolvability increases more rapidly with genotype network size and reaches a higher maximum value for TF binding sites
than for RBP binding sites.
Binding Site Variants in the Human Population. The measures of
robustness and evolvability that we studied here take into con-
sideration all of the DNA and RNA sequences that bind a TF or
RBP, respectively. Moreover, they assume that all types of point
mutations to these sequences are equally likely. However, only
a subset of all DNA and RNA sequences is used for gene reg-
ulation in vivo, and mutations to these sequences may be sub-
ject to biases. These include context-dependent mutation rates
(57) as well as simple transition:transversion biases (58). In other
words, our observations above need not hold for the binding sites
encountered in vivo or for their mutational variants.
To find out if they do, we studied putative TF and RBP bind-
ing sites in humans and the single-nucleotide mutants of these
sequences that exist as standing variation (Materials and Meth-
ods). Specifically, we collected DNaseI footprint data from 41
diverse cell and tissue types (59). These data demarcate protein-
bound regions of the genome at single-nucleotide resolution
genome-wide and can, therefore, be used to predict TF bind-
ing sites. We focused on footprints that are likely to be involved
in gene regulation by filtering the footprints to only include
those that overlap the promoter regions of protein-coding genes.
We also collected RNase footprints from HeLa cells, which
demarcate protein-bound regions of the transcriptome at single-
nucleotide resolution transcriptome-wide and can, therefore, be
used to predict RBP binding sites (60). We focused on footprints
that are likely to be involved in gene regulation by filtering the
footprints to only include those that were in the 5′ or 3′ UTRs
of protein-coding transcripts, because these are common regula-
tory targets of RBPs (49). For each of the DNaseI and RNase
footprints in these regulatory regions, we determined the likely
bound TFs or RBPs based on the available binding data (49, 50)
(Materials and Methods). This resulted in a list of putative binding
sites for each TF and RBP. To determine which mutational vari-
ants of these binding sites exist as standing variation in the human
population, we queried the 1000 Genomes Project Consortium
data for SNPs (61). This allowed us to determine which of a bind-
ing site’s mutational variants likely abrogate binding to the focal
protein and which do not. For those that are likely to abrogate
binding, we determined which other TFs or RBPs the mutational
variant might bind. In this way, we determined the robustness and
evolvability of the set of nucleic acid sequences that are encoun-
tered as putative binding sites in vivo and how these properties
relate to the size of a protein’s genotype network.
Fig. 6A shows that, as the size of a genotype network increases,
so does the number of a binding site’s mutational variants that
exist as standing variation in the human population and that do
not abrogate binding to the focal protein (i.e., the mutational
variants of a binding site are on the same genotype network
as the binding site). This pattern is similar to that of Fig. 2E,
indicating that the relationship between robustness and geno-
type network size is consistent among the subset of binding sites
encountered in vivo and the superset of sequences character-
ized in vitro. Moreover, the distributions of robustness are sta-
tistically indistinguishable among TFs and RBPs (P =0.83, one-
sided Wilcoxon rank sum test), consistent with our observation
that their binding sites are similarly robust to mutation (Fig. 2).
Much of the standing variation in human nucleic acid binding
sites is, therefore, unlikely to abrogate binding, especially for TFs
and RBPs with large genotype networks.
Fig. 6B shows that, as the size of a genotype network increases,
so does the number of TFs or RBPs that are bound by the
one-mutant neighbors of binding sites that abrogate binding to
the focal protein (i.e., the mutational variants of a binding site
are not on the same genotype network as the binding site but
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RBP binding sites. (A) Bar heights show the number of mutations that are
needed to convert two binding sites from different genotype networks into
one another averaged across all pairs of binding sites from all pairs of geno-
type networks and normalized by the length of the binding site. (B) Bar
heights show the number of binding sites that are shared between two
genotype networks averaged over all pairs of genotype networks and nor-
malized by the number of possible binding sites. Note the logarithmic scale
of the y axis. In both panels, the error bars represent a single SD.
rather, are on the genotype network of another protein). This
pattern is similar to that of Fig. 3E, indicating that, like robust-
ness, the relationship between evolvability and genotype net-
work size is consistent among the subset of binding sites encoun-
tered in vivo and the superset of sequences characterized in
vitro. Therefore, mutational variants of TF binding sites in the
human population are more likely to have new binding phe-
notypes than those of RBP binding sites (P < 10−5, one-sided
Wilcoxon rank sum test). This provides support for our main
conclusion that the nucleic acid binding sites of RNA-mediated
gene regulation are less evolvable than those of transcriptional
regulation.
Discussion
The nucleic acid sequences that bind TFs dictate when, where,
and to what extent genes are transcribed. The resulting tran-
scripts comprise nucleic acid sequences that bind RBPs to reg-
ulate much of the transcripts’ lifecycle, including splicing, trans-
port, and decay. Interactions between nucleic acid binding sites
and their cognate regulatory proteins are, therefore, fundamen-
tal to the regulation of gene expression. Here, we used exper-
imental data to study the robustness and evolvability of these
interactions. We did so via a comparative analysis of their
genotype–phenotype maps. In these maps, a genotype is a nucleic
acid sequence, and a phenotype is the molecular capacity of the
sequence to bind a protein (31). For each TF and RBP, we con-
structed a genotype network from the sequences that bind the
protein, and we studied how these genotype networks confer
robustness and evolvability to the binding sites they harbor.
These empirical genotype–phenotype maps exhibit two archi-
tectural differences. First, the genotype networks of RBP binding
sites are often much smaller than those of TF binding sites, which
means that the bindings sites of some RBPs are less robust than
those of TFs. Second, the genotype networks of TF binding sites
interface and overlap with one another more than the genotype
networks of RBP binding sites, rendering the space of TF bind-
ing sites more conducive to the evolution of new binding pheno-
types. This observation is consistent with our analysis of standing
genetic variation in the human population as reported by the 1000
Genomes Project Consortium (61). Specifically, standing varia-
tion in TF binding sites is more likely to confer new binding phe-
notypes than standing variation in RBP binding sites.
There are additional facets to the robustness and evolvability
of transcriptional and RNA-mediated gene regulation that we
do not study here. For example, the robustness of transcriptional
regulation can be enhanced by homotypic clusters of TF binding
sites, shadow enhancers, and redundant TFs (62), whereas the
evolvability of RNA-mediated gene regulation can be enhanced
by alternative splicing, alternative polyadenylation, and RNA
editing (63). Even in the context of nucleic acid binding sites,
which are the focus of this study, there is an additional facet
to evolvability that we do not consider but that may further
contribute to the greater evolvability of TF binding sites. It is
the propensity for binding sites to evolve de novo in regulatory
regions (64, 65). The reason is that, in higher eukaryotes, such as
the species studied here, the transcriptional regulation of gene
expression is typically implemented by a promoter and several
enhancers (66, 67), and each of these can span well over 1 kb of
DNA (68, 69). This is a larger mutational target than the 5′ and
3′ UTRs of transcripts, which in humans, tend to span ∼200 bp
and ∼1 kbp pair, respectively (70). While RBP binding sites are
known to evolve de novo in these regions (71), the larger size of
promoters and enhancers makes it likely that TF binding sites
are also more evolvable in the context of de novo evolution.
Our evolvability measure is specifically concerned with muta-
tions to binding sites that change the binding partner from one
protein to another. Such mutations can indeed lead to adaptive
changes in gene expression as examples from transcriptional reg-
ulation show (11, 72, 73). For instance, the initiation and pro-
gression of cancer are parts of an evolutionary process, in which
mutations facilitate the uncontrolled division and spread of
abnormal cells throughout the body. Such mutations commonly
arise in regulatory regions (72, 74, 75) as evidenced by recurrent
mutations in the binding sites of CEBP TFs, which create high-
affinity binding sites for other TFs (72). These mutations are
found across a diversity of cancer types, which suggests that they
drive a change in gene expression that is selectively advantageous
for cancer cells. We do not know of an analogous example for
RBP binding sites. The reason may be that they are not as well-
studied, that they show lower evolvability, or both.
Our study has three limitations that are worth highlighting.
The first is the size of our dataset. The human genome encodes
∼1,400 TFs and ∼700 mRNA-binding RBPs (6, 76), whereas
our dataset comprises 38 human TFs and 71 human RBPs. The
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Fig. 5. Mutations to TF binding sites bring forth a greater number of new binding phenotypes than the same number of mutations to RBP binding sites.
Each circle corresponds to the average fraction of TFs or RBPs in our dataset (vertical axis) that are bound by a sequence within n mutations (horizontal axis)
of a focal sequence and that are on the same genotype network as the focal sequence. To calculate this average, we separately considered each sequence
in each genotype network as the focal sequence. The average thus includes all sequences that are bound by at least one protein in our dataset from (A) D.
melanogaster or (B) H. sapiens. Note that the maximum mutational distance of a genotype from a focal sequence on the same genotype network depends
both on the location of the focal sequence in the genotype network and on the diameter of the genotype network. The binding sites of TFs have a greater
number of new binding phenotypes than those of RBPs within a mutational radius of n for all n [(A) P= 0.011 for n= 0, P= 0.002 for n= 1, and P< 10−3
for 3≤ n≤ 7, one-sided Wilcoxon rank sum test; (B) P< 10−5 for 0≤ n≤ 7, one-sided Wilcoxon rank sum test]. Error bars depict a single SD. Data are offset
in the horizontal direction for clarity. The legend in B applies to A as well.
inclusion of more proteins will necessarily affect the architecture
of the genotype–phenotype maps that we study. However, the
consistency of our conclusions across the D. melanogaster and H.
sapiens datasets, which comprise different binding domains and
different numbers of proteins per binding domain, provides reas-
surance that our findings are general. The second limitation is
that we use indirect evidence of in vivo protein–nucleotide inter-
actions, because footprinting assays do not reveal which proteins
are bound by a specific nucleic acid sequence. We ameliorate
this limitation by only studying footprints that contain sequences
that bind the proteins in our dataset. Ideally, however, we would
study data from assays that provide direct evidence of protein–
nucleotide interactions (77, 78), but these data are available nei-
ther for most of the proteins in our dataset nor for the 1000
Genomes Project Consortium data. The third limitation is the
length of the binding sites that we study, which are represen-
tative of the binding preferences of many but not all TFs and
RBPs (49, 50). For example, Cys2-His2 zinc finger proteins typi-
cally bind longer sequences (79), to which we cannot extrapolate
our findings. As our ability to predict (80) and measure (81) the
binding preferences of such proteins continues to advance, it will
become possible to extend our analyses to longer nucleic acid
ligands.
In sum, our comparative analysis of two empirical genotype–
phenotype maps suggests that the nucleic acid binding sites of
RNA-mediated gene regulation are less evolvable than those of
transcriptional regulation. This observation is consistent with the
high levels of mRNA target conservation for RBPs (10, 82, 83)
and the evolutionary plasticity of the regulatory regions involved
in transcriptional regulation (84–86) as well as their role in the
evolution of myriad adaptations and innovations (11, 87, 88).
Materials and Methods
Protein Binding Microarray and RNAcompete Data. The largest databases for
protein binding microarray and RNAcompete data are CIS-BP (50) and CISBP-
RNA (49), respectively. There is currently far more protein binding microarray
data available than RNAcompete data. Specifically, the most recent build of
the CIS-BP database (version 1.02) contains protein binding microarray data
for 1,665 TFs from 132 species, whereas the most recent build of the CISBP-
RNA database (version 0.6) contains RNAcompete data for 194 RBPs from
24 eukaryotic species. Our choice of study species was, therefore, guided by
the availability of the RNAcompete data, because they are more limited. We
chose to study proteins from D. melanogaster and H. sapiens, because these
species have more RNAcompete data available than any of the other species
(Table 1 and Dataset S1). We limited our study to two species, because the
species with the next largest number of RBPs in the CISBP-RNA database was
Caenorhabditis elegans, which had only 15 RBPs profiled.
More specifically, we downloaded protein binding microarray data for 30
D. melanogaster and 38 H. sapiens TFs from the CIS-BP database (version
1.02) (50), and we downloaded RNAcompete data for 33 D. melanogaster
and 71 H. sapiens RBPs from the web supplement of ref. 49. Both the protein
binding microarray and RNAcompete data include a nonparametric rank-
based enrichment score (E-score) that can be used to delineate sequences
that specifically bind a TF or RBP from those that do not. The protein bind-
ing microarray data include an E-score for all possible 8-nt dsDNA sequences.
The total number of such sequences is (48− 44)/2+ 44 = 32, 896 rather than
48 = 65, 536, because each sequence is merged with its reverse comple-
ment and because there are 44 sequences that are identical to their reverse
complement and therefore, cannot be merged (89). The RNAcompete data
include an E-score for nearly all possible 7-nt ssRNA sequences. The total
number of such sequences is 47− 2= 16, 382, where the −2 accounts for
the two sequences (GCTCTTC and GAAGAGC) that contain an SapI restriction
site, which is used during the RNA pool synthesis to remove linker sequences
from PCR products (46). The data from these two experimental protocols are
comparable, because the numbers of nucleic acid sequences profiled are of
the same order of magnitude and because the E-score is calculated in the
same way and has the same meaning in the two datasets. Following earlier
work (31, 41, 52), we consider a sequence to bind a TF or an RBP if its E-score
exceeds 0.35. We chose this threshold not only because it has precedent (31,
41, 52, 53), but also because an analysis of the relationship between E-score
and false discovery rate for 104 mouse TFs revealed that sequences with an
E-score greater than 0.35 had a false discovery rate less than 0.001 (31). In
SI Appendix, we perform a sensitivity analysis of our results to this binding
affinity threshold.
For each TF and RBP, E-scores were provided from two distinct array
designs. We considered the E-score of a DNA or RNA sequence to be the
average of the two E-scores. To include a TF or RBP in our dataset, we
required that it bind at least one sequence (i.e., that at least one sequence
had an average E-score> 0.35). For 1 TF and for 12 RBPs, data were available
from more than one experiment. For these proteins, we chose the experi-
ment with the largest number of bound sequences (Dataset S1) to avoid any
bias toward small genotype networks in the genotype–phenotype map of
RBP binding sites. In a supplementary analysis reported in SI Appendix, Fig.
S5, we studied RNAcompete data for an additional 68 RBPs. We processed
these in the same way as the data from the 33 D. melanogaster and 71 H.
sapiens RBPs. In supplementary analyses reported in SI Appendix, Figs. S9–
S12, we studied the space of all possible 47/2= 8, 192 7-nt dsDNA sequences
(note that, in this case, we do not have to account for sequences that are
Payne et al. PNAS | vol. 115 | no. 15 | E3487
10-4 10-3 10-2
Fractional size of genotype network
0
0.1
0.2
0.3
0.4
0.5
R
ob
us
tn
es
s
A
0 0.01 0.02 0.03
Fractional size of genotype network
0
0.2
0.4
0.6
0.8
1
Ev
ol
va
bi
lity
B
TF, human
RBP, human
Fig. 6. Analysis of human DNA polymorphisms shows that the binding sites
of TFs and RBPs exhibit similar robustness to mutation, yet those of TFs are
more likely to bring forth new binding phenotypes. (A) Robustness (verti-
cal axis), defined as the fraction of a TF’s or RBP’s binding site variants that
remain on the focal protein’s genotype network, shown in relation to the
fractional size of the genotype network (horizontal axis). (B) Evolvability
(vertical axis), defined as the fraction of TFs or RBPs in our dataset that are
bound by the binding site variants that do not remain on the focal protein’s
genotype network, shown in relation to the fractional size of the genotype
network (horizontal axis). Binding site variants are from phase 3 of the 1000
Genomes Project Consortium (61). Black symbols correspond to the robust-
ness and evolvability of binding sites in DNaseI footprints that overlap pro-
moters averaged across 41 cell and tissue types. White symbols correspond
to the robustness and evolvability of binding sites in RNase footprints that
overlap the 5′ and 3′ UTRs of transcripts in HeLa cells.
identical to their reverse complement, because such sequences only exist
when the sequence length is an even number). We used the same analysis
pipeline to calculate E-scores for these sequences as used for the 8-nt DNA
sequences studied in the text.
Both the CIS-BP and the CISBP-RNA databases have been updated since
their original release. This is why our calculation of the total number of
TFs and RBPs in these databases does not match the numbers reported
in the original manuscripts (49, 50). We calculated the number of TFs and
species in the CIS-BP database by entering “PBM” as “By Evidence Type” on
the homepage of the CIS-BP website and downloading the resulting .csv
file. We removed all TFs labeled as “PBM CONTRUCTS” in the “Species”
column and then counted the number of TFs and the number of unique
species. Analogously, we calculated the number of RBPs and species in the
CISBP-RNA database by entering “RNAcompete” as By Evidence Type in the
homepage of the CISBP-RNA website and downloading the resulting .csv
file. We removed all RBPs labeled as “RNAcompete CONSTRUCTS” in the
Species column and counted the number of RBPs and the number of unique
species.
Human Polymorphism Data. We used data from phase 3 of the 1000
Genomes Project, which includes 84.7 million SNPs from 2,504 individuals
representing 26 human populations (61). We filtered the dataset to only
include SNPs that passed quality control. These data and the data described
below pertain to build hg19 of the human genome.
We sought to determine the amount of variation in TF and RBP bind-
ing sites. To do so, we first identified regions of the human genome that
may be involved in gene regulation by TFs or RBPs. For TFs, we identi-
fied protein-bound regions of gene promoters using digital footprints from
DNaseI hypersensitivity assays (59). These data provide genome-wide evi-
dence of protein–DNA interactions across 41 cell and tissue types at single-
nucleotide resolution. We used BEDTools to filter the footprints (90), such
that we only retained footprints that overlapped promoter regions by at
least 1 bp. We defined the promoter region of a gene to be the DNA
sequence 1 kb upstream of the gene’s transcription start site. We restricted
our attention to genes encoding mRNA as indicated by the prefix NM in
the RefSeq database (91). For these same genes, we identified 5′ and 3′
UTRs as potential regulatory targets for RBPs. We identified protein-bound
regions in mRNA transcripts using footprints from an RNase hypersensitiv-
ity assay (60), which provides transcriptome-wide evidence of protein–RNA
interactions in HeLa cells. We used bedtools to filter the footprints, such
that we only retained footprints that overlapped 5′ and 3′ UTRs by at least
1 bp.
For each TF, we scanned each promoter footprint for potential TF binding
sites, and for each RBP, we scanned each 5′ UTR footprint and each 3′ UTR
footprint for potential RBP binding sites. The scanning worked as follows. If
a footprint contained at least one sequence with an E-score > 0.35 for the
TF or RBP, then we considered this sequence to be a potential binding site.
If the footprint contained more than one binding site, then we randomly
chose one of them for later analysis. We chose to assign only one binding
site per footprint per TF or RBP to avoid any bias that may be introduced by
the different lengths of DNaseI footprints and RNase footprints.
The above procedure resulted in a list of genomic coordinates of poten-
tial binding sites for each TF and RBP. The number of such TF binding sites
ranged from 266 for the TF POU6F1 in HFF cells to a maximum of 50,126 for
the TF DNMT1 in NB4 cells. The number of such RBP binding sites ranged
from 0 for the RBPs ENOX1, FXR2, and ZNF638 to a maximum of 32,272 for
the RBP HNRNPH2. For each of these potential binding sites, we used the
Samtools function tabix to query the 1000 Genomes Consortium data for
SNPs (92). We used the results of these queries to calculate the proportion
of binding site variants that is on the focal TF’s or RBP’s genotype network
and the proportion that is not. For those variants that are not on the geno-
type network, we calculated the fraction of TFs or RBPs in our dataset that
these variants have the potential to bind.
Genotype Networks. We constructed a genotype network for each TF and
RBP following the procedure of Payne and Wagner (31). Specifically, for
each protein, we used the Smith–Waterman algorithm to perform a pair-
wise alignment on all pairs of bound sequences (E-score > 0.35), in which
we prohibited gaps. We then calculated the mutational distance m(s1, s2)
between two sequences s1 and s2 as the number of mismatches in the align-
ment of these sequences. We represented bound sequences as vertices in the
network, and we connected two vertices by an edge if their corresponding
sequences differed by a single small mutation. We considered point muta-
tions and small indels that shift an entire contiguous binding site by a single
base (31). For TFs, we calculated the mutational distance between two DNA
sequences s1 and s2 as the minimum of the mutational distance m(s1, s2) and
m(s1, s
′
2), where s
′
2 is the reverse complement of s2. For RBPs, we calculated
the mutational distance between two RNA sequences s1 and s2 as m(s1, s2).
We constructed genotype networks in this way using the Genonets Server
(51), which we also used to measure robustness and evolvability as well as
the overlap among genotype networks.
Statistical Analysis. We use the nonparametric, one-sided Wilcoxon rank
sum test of the null hypothesis that the distributions of samples x and y
come from distributions with equal medians against the alternative hypoth-
esis that y is sampled from a distribution with a median that is greater than
that of the distribution from which x was sampled. We do not distinguish
between P values that are less than 10−5.
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